Vol. 151, No. 26 — December 27, 2017

19204-2 N

Glycerides, alkyl and alkynyl, esters with polyethylene glycol ether with glycerol (3:1)

Esters de propane-1,2,3-triol et d’acides gras saturés ou insaturés, esters avec de l’oxyde de poly(éthane-1,2-diol) et de propane-1,2,3-triol (3/1)

19207-5 N

Glycerides, alkyl and alkynyl, esters with polyalkylene glycol ether with glycerol (3:1)

Esters de propane-1,2,3-triol et d’acides gras saturés ou insaturés, esters avec de l’oxyde de poly(alcanediol) et de propane-1,2,3-triol (3/1)

19209-7 N-P

Alkanethiol, [1,2-ethanediylbis(oxy)]bis-, polymer with 1,1′-[oxybis(2,1-ethanediyloxy)]bis[ethene], [[3-(2-oxiranylmethoxy)propyl]thio]-terminated, polymers with 2(or 4)-methyl-4,6(or 2,6)-bis(methylthio)-1,3-benzenediamine

[(Éthane-1,2-diyl)bis(oxy)]bisalcanethiol polymérisé avec de l’[oxybis(éthane-2,1-diyloxy)]bis[éthène], à terminaisons [[3-(oxiranylméthoxy)propyl]thio], polymérisé avec de la 3-amino-2(ou 4)-méthyl-4,6(ou 2,6)-bis(méthylthio)aniline

18563-5 N-S

1 The use, in the manufacture of coatings or adhesives that are consumer products to which the Canada Consumer Product Safety Act applies, of the substance 2-propenoic acid, 2-methyl-, alkyl ester, polymer with ethenylbenzene, methyl 2-methyl-2-propenoate and 2-oxiranylmethyl 2-methyl-2-propenoate, tert-Bu peroxide-initiated in a quantity greater than 1000 kg in a calendar year and in such a manner that the substance is present in the coating or adhesive.

2 The use, in a quantity greater than 1000 kg in a calendar year, of the substance 2-propenoic acid, 2-methyl-, alkyl ester, polymer with ethenylbenzene, methyl 2-methyl-2-propenoate and 2-oxiranylmethyl 2-methyl-2-propenoate, tert-Bu peroxide-initiated in coatings or adhesives that are consumer products to which the Canada Consumer Product Safety Act applies.

3 Sections 1 and 2 do not include

• (a) the use of the substance as a research and development substance or site-limited intermediate substance as those terms are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers); or
• (b) the use of the substance in a consumer product, as described in those sections, that is for export only.

4 For each proposed significant new activity, the following information must be provided to the Minister at least 90 days before the day on which the activity begins:

• (a) a description of the significant new activity in relation to the substance;
• (b) the anticipated annual quantity of the substance to be used;
• (c) the information specified in items 1, 3 to 7, 9 to 12 and in subparagraphs 13(d)(i) to (iii) of Schedule 9 to the New Substances Notification Regulations (Chemicals and Polymers);
• (d) if the significant new activity involves the use of the substance in a quantity greater than 50 000 kg in a calendar year, the information specified in paragraph 11(3)(a) of those Regulations;
• (e) the information specified in items 5(a) and 5(c) to (h) of Schedule 10 to those Regulations;
• (f) the information specified in item 10 of Schedule 11 to those Regulations;
• (g) the name of every government department or government agency, either outside or within Canada, to which the person proposing the significant new activity has provided information regarding the use of the substance and, if known, the department’s or agency’s file number and, if any, the outcome of the department’s or agency’s assessment and the risk management actions in relation to the substance imposed by the department or agency;
• (h) the test data and the test report from a skin sensitization study, that in respect of the substance, establishes the minimal concentration inducting a proliferation in draining lymph nodes that is threefold above the negative control (EC₃ value) and that is conducted in accordance with the Organisation for Economic Co-operation and Development (OECD) Guideline for the Testing of Chemicals No. 429, entitled Skin Sensitization: Local Lymph Node Assay, that is current at the time the study is conducted;
• (i) all other information or test data in respect of the substance that are in the possession of the person who is proposing the significant new activity or to which they may reasonably be expected to have access and that permit the identification of hazards to the environment and human health and the degree of environmental and public exposure to the substance;
• (j) the name, civic and postal addresses, telephone number and, if any, the fax number and email address of the person who is proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada who is authorized to act on their behalf; and
• (k) a certification that the information is accurate and complete, dated and signed by the person who is proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada who is authorized to act on their behalf.

5 The study referred to in paragraph 4(h) must be conducted by a laboratory whose practices conform with those described in the OECD Principles of Good Laboratory Practice set out in Annex II of the Decision of the Council Concerning the Mutual Acceptance of Data in the Assessment of Chemicals, adopted on May 12, 1981 by the OECD, using the Principles of Good Laboratory Practice that is current at the time the study is conducted.